爱尔康公司是全球最大的眼科药品与医疗器械专业公司，主要经营眼部医药品、眼科手术设备装置、隐形眼镜相关护理产品的研发、生产和营销。
然而，爱尔康的其他股东就没那么高兴了。
Alcon's remaining shareholders are less than pleased, however.
控股爱尔康进而将其整合而节省成本所带来的利润无法实现。
But it also defers the benefits that full control might bring in terms of saving costs by integrating Alcon into its business.
美国的收购法案也使得诺华对爱尔康这种情况的发生微乎其微。
America's rules on takeovers would also make this sort of occurrence impossible in most cases.
应用推荐